AdaptHealth Corp. to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement
AdaptHealth Corp. (NASDAQ: AHCO) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $13.00 price target on the stock.
Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. (AHCO) an Upcoming Claims Deadline in a Class Action Settlement
AdaptHealth Is Too Strong To Be Valued At 40% Of Revenues [Seeking Alpha]